An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy

MLA

Yuefeng Yang, et al. “An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.” Human Gene Therapy, vol. 30, Sept. 2019, pp. 1117–32. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6cd4dd73264b4c681f459c6c15956020&authtype=sso&custid=ns315887.

APA

Yuefeng Yang, Feng-Jun Xiao, Kathy A. Mangold, Yuan Ji, Megan E. Sullivan, Jinnan Li, Hao Wang, Xiaoyan Zhang, Prem Seth, Yitan Zhu, Xuejie Wu, Kamalakar Gulukota, Weidong Xu, Bellur S. Prabhakar, Lisheng Wang, Donald L. Helseth, Edward Wang, Hua Wang, Karen L. Kaul, & Di Peng. (2019). An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy. Human Gene Therapy, 30, 1117–1132.

Chicago

Yuefeng Yang, Feng-Jun Xiao, Kathy A. Mangold, Yuan Ji, Megan E. Sullivan, Jinnan Li, Hao Wang, et al. 2019. “An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.” Human Gene Therapy 30 (September): 1117–32. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6cd4dd73264b4c681f459c6c15956020&authtype=sso&custid=ns315887.